Equities
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.

  • Revenue in EUR (TTM)1.90bn
  • Net income in EUR293.91m
  • Incorporated1995
  • Employees4.22k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AFXX:GER since
announced
Transaction
value
Kogent Surgical LLCDeal completed19 Apr 202219 Apr 2022Deal completed6.32%--
Katalyst Surgical LLCDeal completed19 Apr 202219 Apr 2022Deal completed6.32%--
Data delayed at least 15 minutes, as of Feb 07 2023 08:19 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Elekta AB (publ)1.34bn72.42m2.51bn4.66k35.963.2515.291.882.162.1639.9123.890.59723.402.843,209,640.003.254.845.998.8637.1241.035.448.880.75584.650.384755.055.706.33-7.9755.9812.7119.14
Ypsomed Holding AG488.35m31.54m2.53bn2.00k75.844.9423.975.172.432.4337.6137.290.63795.416.20252,988.604.124.976.407.5526.0927.306.467.000.45710.380.249324.1815.163.60297.61-12.9627.27-14.33
Ambu A/S596.75m12.49m3.07bn4.41k275.016.0959.465.140.37160.371617.5316.770.68611.926.151,007,938.001.445.081.726.2757.4760.062.097.080.932--0.302227.9410.7413.54-62.35-20.9428.54--
GN Store Nord A/S2.35bn89.97m3.40bn8.17k35.403.2811.501.455.225.22136.8056.290.71873.064.892,423,492.002.959.044.3812.2051.4258.314.1111.120.51925.590.691133.6317.2912.7740.2610.0914.206.15
Getinge AB2.48bn218.41m5.49bn11.11k26.932.2314.532.219.159.15103.87110.280.58582.715.68--5.213.976.545.1847.4047.998.906.561.5725.030.160539.884.604.69-16.1317.85-7.3423.16
ConvaTec Group PLC1.93bn74.65m5.54bn10.03k73.663.7520.342.860.03280.03280.85070.64540.55863.116.10172,238.402.163.202.533.5954.1154.243.866.310.99372.700.475994.567.603.844.53--6.74--
Amplifon SpA2.07bn178.28m6.45bn12.59k35.89--15.483.120.79410.76859.22--------164,390.30--4.61--6.1224.7555.818.637.24--9.02--29.1029.5911.4564.6720.1212.6530.01
Demant A/S2.51bn355.18m6.69bn18.13k18.826.35--2.6711.4910.3781.1234.060.73282.055.311,106,131.0010.429.0718.4914.7875.1675.2314.2211.960.587945.490.62120.0023.758.33140.5013.0711.99--
Smith & Nephew plc4.86bn462.28m11.54bn18.00k25.082.2911.492.380.47050.47054.955.150.49560.80754.13236,178.504.726.695.908.0871.0372.549.5112.340.83567.990.349152.9014.302.2216.96-7.740.80335.28
Carl Zeiss Meditec AG1.90bn293.91m12.34bn4.22k42.106.1375.656.493.283.2821.2322.530.72922.329.92450,482.0011.349.1514.1011.2059.2657.4715.5512.382.618.920.097635.2515.559.8424.3916.9316.0014.87
Koninklijke Philips NV17.83bn-1.62bn14.38bn79.10k------0.8065-1.84-1.8220.25------------1.64--2.2540.3544.42-9.082.62--4.77----3.910.0528-366.61---1.27--
Sonova Holding AG3.62bn648.56m14.92bn17.07k23.197.3716.834.1210.4810.4858.5533.000.65962.827.71215,544.1012.0310.5016.1913.5571.1171.8018.2417.470.841230.490.456133.6529.297.0214.2012.581.6513.85
Data as of Feb 07 2023. Currency figures normalised to Carl Zeiss Meditec AG's reporting currency: Euro EUR
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.